Civica Rx Welcomes New Founding Members as 12 Additional Health Systems Join Forces to Reduce Chronic Drug Shortages

Momentum reflects commitment of nearly 750 hospitals to date

SALT LAKE CITY–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/CivicaRx?src=hash” target=”_blank”gt;#CivicaRxlt;/agt;–Civica Rx has announced that 12 health systems, representing
approximately 250 hospitals across the United States, have joined the
new not-for-profit generic drug company as founding members. When
combined with hospitals represented by the initial governing members of
Civica Rx, approximately 750 U.S. hospitals have joined the
mission-driven venture so far, with many more health systems expressing
interest.

Civica
Rx was established in 2018 by three philanthropies and seven leading
health systems that experience first-hand the impact of drug shortages,
which have become all too common and affect all aspects of the health
care delivery system. The highly-collaborative initiative will result in
lower costs and more predictable supplies of many medicines, helping
ensure that patients and their needs come first in the generic drug
marketplace.

Civica Rx members drive drug selection decisions to ensure Civica Rx
manufactures the medications that are most essential to patient care.
The 12 new founding members include:

• Advocate Aurora Health
• Allegheny Health Network
• Baptist Health South Florida
• Franciscan Alliance
• Memorial Hermann Health System
• NYU Langone Health
• Ochsner Health System
• Sanford Health
• Spectrum Health
• St. Luke’s University Health Network
• Steward Health Care
• UnityPoint Health

“We are thrilled to welcome these highly-regarded health systems to
Civica as founding members,” said Martin VanTrieste, CEO of Civica Rx.
“Drug shortages have become a national crisis where patient treatments
and surgeries are canceled, delayed or suboptimal. We thank these
organizations for joining us to make essential generic medicines
accessible and affordable in hospitals across the country.”

Civica Rx expects to bring over 14 hospital-administered generic drugs
to hospitals and health care systems in 2019 as the initial focus of the
company’s efforts, with many additional medications prioritized by the
healthcare systems as the next phase of focus. The company is working
towards becoming an FDA approved manufacturer and will either directly
manufacture generic drugs or sub-contract manufacturing to trusted
supply partners.

These founding members join the previously announced governing members
of Civica Rx, which include Catholic Health Initiatives, the Gary and
Mary West Foundation, HCA Healthcare, Intermountain Healthcare, Laura &
John Arnold Foundation, Mayo Clinic, the Peterson Center on Healthcare,
Providence St. Joseph Health, SSM Health, and Trinity Health. Civica Rx
is collaborating with the American Hospital Association’s (AHA) newly
formed AHA Center for Health Innovation to address inquiries
about the initiative. Health systems and hospitals may
call 800-242-4677 with questions, or visit www.civicarx.org
for information.

Contacts

Civica Rx
Lance Madigan
Corporate Communications Manager
801-442-3217
lance.madigan@imail.org